Angelalign sets 2026 AGM to approve 2025 results and share issuance mandate

Angelalign Technology Inc. ( (HK:6699) ) has provided an update.

Angelalign Technology Inc. has called its annual general meeting for 9:00 a.m. on May 19, 2026, in Shanghai, where shareholders will review the audited financial statements and directors’ and auditor’s reports for the year ended December 31, 2025. The AGM will also seek shareholder approval to grant the board a general mandate to issue new shares and related securities, within specified limits, potentially increasing the company’s capital-raising flexibility and providing management with additional tools to support future business development and strategic initiatives.

The proposed share issuance mandate would allow directors to allot, issue, or otherwise deal with additional shares and convertible securities, subject to a cap of 10% of the company’s issued share capital, plus any shares repurchased under separate approvals. This kind of authorization is standard among Hong Kong–listed issuers and, if approved, would help Angelalign respond more swiftly to market opportunities, though it may also raise shareholder considerations around dilution and capital allocation discipline.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$91.89 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

More about Angelalign Technology Inc.

Angelalign Technology Inc. is a Cayman Islands–incorporated company listed in Hong Kong, focused on the orthodontic and dental technology sector. The company develops and sells clear aligner solutions and related dental products, targeting the growing demand for advanced orthodontic treatments in mainland China and broader Asian markets.

Average Trading Volume: 824,490

Technical Sentiment Signal: Buy

Current Market Cap: HK$15.24B

See more data about 6699 stock on TipRanks’ Stock Analysis page.